Zhejiang University Researchers Highlight Research in Multiple Myeloma (The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China)

Press/Media: Research

PeriodDec 30 2022

Media coverage

1

Media coverage

  • TitleZhejiang University Researchers Highlight Research in Multiple Myeloma (The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China)
    Media name/outletNewsRx Hematology Daily
    Country/TerritoryUnited States
    Date30/12/22
    PersonsYang Yang